Balance Labs, Inc.
BLNC
$0.183
-$0.0095-4.94%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1.07% | 1.52% | |||
| Gross Profit | -1.07% | -1.52% | |||
| SG&A Expenses | -54.74% | 215.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.54% | 44.56% | |||
| Operating Income | 23.54% | -44.56% | |||
| Income Before Tax | 38.95% | -91.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 38.95% | -91.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.95% | -91.46% | |||
| EBIT | 23.54% | -44.56% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 39.33% | -93.48% | |||
| Normalized Basic EPS | 16.67% | -27.27% | |||
| EPS Diluted | 39.33% | -93.48% | |||
| Normalized Diluted EPS | 16.67% | -27.27% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||